733
edits
Heart Failure: Difference between revisions
Jump to navigation
Jump to search
→Therapy of acute heart failure
| Line 548: | Line 548: | ||
Renal failure | Renal failure | ||
|40 mg | |40 mg | ||
125 mg – max 1000 mg | |||
|- | |- | ||
| | | | ||
| Line 555: | Line 555: | ||
Renal failure | Renal failure | ||
|1 mg | |1 mg | ||
3 mg – max 25 mg | |||
|- | |- | ||
|'''Vasodilators''' | |'''Vasodilators''' | ||
| Line 800: | Line 800: | ||
*Valsartan | *Valsartan | ||
| | | | ||
|Start | |Start 40mg twice daily | ||
3-5 weeks | 3-5 weeks 80mg twice daily. | ||
>7 weeks | >7 weeks 160mg twice daily. | ||
|- | |- | ||
|colspan="3" bgcolor="#F0F0F0 "|'''Hydralazine and isosorbide dinitrate (H-ISDN)''' | |colspan="3" bgcolor="#F0F0F0 "|'''Hydralazine and isosorbide dinitrate (H-ISDN)''' | ||